Want to see SG:AP4 full AI Analyst Report?
AP4 Stock Chart & Stats
S$0.84
S$0.03(2.98%)
At close: 4:00 PM EDT
S$0.84
S$0.03(2.98%)
Day’s Range― - ―
52-Week RangeS$0.67 - S$0.99
Previous CloseN/A
Volume2.01M
Average Volume (3M)4.77M
Market Cap
S$1.20B
Enterprise ValueS$1.08K
Total Cash (Recent Filing)S$576.00M
Total Debt (Recent Filing)S$1.18M
Price to Earnings (P/E)17.8
Beta0.45
Next Earnings
Nov 11, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield7.68%
Share Statistics
EPS (TTM)0.14
Shares Outstanding1,484,904,000
10 Day Avg. Volume8,088,999
30 Day Avg. Volume4,774,049
Financial Highlights & Ratios
PEG Ratio-0.75
Price to Book (P/B)2.76
Price to Sales (P/S)4.24
P/FCF Ratio18.98
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
S$1.11Price Target Upside31.55% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)0.14
Revenue Forecast (FY)S$1.09B
Bulls Say, Bears Say
Bulls Say
Near-zero Leverage Balance SheetNear-zero debt-to-equity materially limits interest and refinancing risk while preserving capacity to fund operations, dividends or investment through industry cycles. This gives Riverstone financial flexibility even as profitability normalizes.
Resilient ProfitabilityA 2025 net margin of about 21% and EBIT margin near 25% indicate the core business still converts revenue into substantial profit. This profitability provides resilience and internal funding capacity, although it is below earlier peaks.
Strong Cash GenerationOperating cash flow of about 295M and free cash flow of about 214M, with FCF up 9.9% in 2025, support self-funded operations and shareholder distributions. Durable cash generation is a key buffer against softer demand.
Bears Say
Recent Revenue ContractionThe 6.3% 2025 revenue decline signals demand or volume normalization after the stronger 2024 result. If sustained, weaker top-line momentum can constrain operating leverage and future profit expansion over the medium term.
Margin CompressionMargins have compressed materially from the unusually high 2020–2021 levels, reducing the earnings cushion available if costs rise or demand weakens. The business remains profitable, but normalized margins imply less upside from operating leverage.
Uneven Earnings-to-cash ConversionFree cash flow was only about 73% of 2025 net income and has been volatile over the cycle, including a step-down from 2020–2021 peaks. This creates an ongoing earnings-conversion watchpoint for reinvestment and distributions.
Riverstone Holdings News
AP4 FAQ
What was Riverstone Holdings Limited’s price range in the past 12 months?
Riverstone Holdings Limited lowest share price was S$0.67 and its highest was S$0.98 in the past 12 months.
What is Riverstone Holdings Limited’s market cap?
Riverstone Holdings Limited’s market cap is S$1.20B.
When is Riverstone Holdings Limited’s upcoming earnings report date?
Riverstone Holdings Limited’s upcoming earnings report date is Nov 11, 2026 which is in 80 days.
How were Riverstone Holdings Limited’s earnings last quarter?
Riverstone Holdings Limited released its earnings results on Aug 12, 2026. The company reported S$0.023 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Riverstone Holdings Limited overvalued?
According to Wall Street analysts Riverstone Holdings Limited’s price is currently Undervalued.
Does Riverstone Holdings Limited pay dividends?
Riverstone Holdings Limited pays a Semiannually dividend of S$0.016 which represents an annual dividend yield of 7.68%. See more information on Riverstone Holdings Limited dividends here
What is Riverstone Holdings Limited’s EPS estimate?
Riverstone Holdings Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Riverstone Holdings Limited have?
Riverstone Holdings Limited has 1,484,904,000 shares outstanding.
What happened to Riverstone Holdings Limited’s price movement after its last earnings report?
Riverstone Holdings Limited reported an EPS of S$0.023 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 0.592%.
Which hedge fund is a major shareholder of Riverstone Holdings Limited?
Currently, no hedge funds are holding shares in SG:AP4
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Riverstone Holdings Stock Smart Score
Company Description
Riverstone Holdings Limited
Riverstone Holdings Limited, an investment holding company, primarily manufactures and distributes gloves for both cleanroom and healthcare applications from its base in Malaysia. Its extensive cleanroom product line encompasses finger cots, static-shielding and packaging bags, face masks, and wipers. The company also offers a wide array of other consumables, including hairnets, antistatic gloves, conductive latex finger cots, static-dissipative footwear (shoes, safety booties, and shoe covers), cleanroom coveralls, ESD rubber bands, sticky mats and rollers, polyester and microfiber swabs, and specialized cleanroom papers. For the healthcare sector, Riverstone provides various medical products, notably nitrile examination gloves in blue, white, black, and accelerator-free options. In addition to its manufacturing activities, the company trades in latex products and distributes cleanroom supplies. These offerings are sold under the RS brand and are utilized across the hard disk drive, semiconductor, and healthcare industries. With a global presence, Riverstone exports its products to Asia, Europe, and the Americas. Founded in 1989, Riverstone Holdings Limited is headquartered in Singapore and operates as a subsidiary of Raffles Nominees (PTE.) Limited.
AP4 Stock 12 Month Forecast
Average Price Target
S$1.11
▲(31.55% Upside)
Technical Analysis
Raffles Medical Group
―
Thomson Medical Group Ltd.
―
Aoxin Q&M Dental Group Ltd.
―
Asiamedic Limited
―
OUE Lippo Healthcare Limited
―








